CHARLES RIVER LABORATORIES INC
10-Q, EX-27, 2000-08-08
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CHARLES RIVER LABORATORIES INC, 10-Q, 2000-08-08
Next: RESIDENTIAL ASSET MORTGAGE PRODUCTS INC, 8-K, 2000-08-08



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM THE CONSOLIDATED
STATEMENT OF EARNINGS FOR THE SIX MONTHS ENDED JUNE 24, 2000 AND THE
CONSOLIDATED BALANCE SHEET AT JUNE 24, 2000 AND IS QUALIFIED IN ITS ENTIRITY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-30-2000
<PERIOD-END>                               JUN-24-2000
<CASH>                                          18,993
<SECURITIES>                                         0
<RECEIVABLES>                                   50,930
<ALLOWANCES>                                       976
<INVENTORY>                                     32,192
<CURRENT-ASSETS>                               108,388
<PP&E>                                         117,741
<DEPRECIATION>                                 143,049
<TOTAL-ASSETS>                                 398,247
<CURRENT-LIABILITIES>                           69,625
<BONDS>                                        311,102
                                0
                                          0
<COMMON>                                             1
<OTHER-SE>                                    (17,024)
<TOTAL-LIABILITY-AND-EQUITY>                   398,427
<SALES>                                        143,399
<TOTAL-REVENUES>                               143,399
<CGS>                                           83,912
<TOTAL-COSTS>                                   83,912
<OTHER-EXPENSES>                                26,042
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              19,162
<INCOME-PRETAX>                                 14,804
<INCOME-TAX>                                     2,151
<INCOME-CONTINUING>                             12,653
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    12,722
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission